Search results
Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation
Reuters via Yahoo News· 1 year agoThe blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and...
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
Investor's Business Daily· 10 months agoThere's a piece of bad news for Novo Nordisk's massively popular diabetes drug Ozempic in Medicare's...
UPDATE 7-Blood thinners, diabetes meds among first 10 drugs for US price negotiations
Reuters via Yahoo Finance· 10 months agoThe Biden administration on Tuesday released its list of 10 prescription medicines that will be...
Medicare names first 10 drugs up for price negotiation with government
NBC News via Yahoo News· 10 months agoThe Centers for Medicare and Medicaid Services on Tuesday announced the first 10 prescription drugs...
Important News Update: How To Save on All of Your Prescriptions
First for Women via Yahoo News· 9 months agoOn August 29, 2023, the Biden administration unveiled the first 10 drugs that will be subjects of...
Bristol Myers (BMY) Gains 24.2% YTD: What's in Store for 2023?
Zacks via Yahoo Finance· 2 years agoBiotech giant Bristol Myers (BMY) outperforms the industry and the S&P 500 Index as Eliquis and...
2 Pharma Stocks With Blockbuster Drugs on the Horizon
Motley Fool· 2 years agoAbbVie's Humira, used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic...
Column: Big drug makers are whining about having to negotiate with Medicare, but they can't afford...
LA Times via Yahoo Finance· 8 months agoMedicare is finally allowed to negotiate prescription drug prices with drug companies. But the...
Pharma companies raise prices on over 900 drugs amid 'historic' negotiations
USA TODAY via Yahoo News· 4 months agoAs the federal government seeks to rein in drug prices, pharmaceutical companies this year have been...
Biden targets diabetes drug Jardiance, blood thinner Eliquis, and 8 others for controversial...
Fortune via Yahoo Finance· 10 months agoThe move is expected to cut costs in a few years for some patients but faces litigation from the...